Testing effectiveness (Phase 2)Looking for participantsNCT07104565
What this trial is testing
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
Who this might be right for
Immune Thrombocytopenia
Incyte Corporation 56